Impact of Spinal Anesthesia Dosage in Elective Cesarean Section on the Duration of Stay in Post-Anesthesia Care Unit at the Women’s Health Hospital, National Guard Health Affairs

In the field of obstetrics, cesarean sections have now become the most prominent procedure for the delivery of newborns. Cesarean sections may be handled with a variety of different anesthetic approaches, of which most focus seems to be on that of spinal forms, due to their rapid and effective action. Dosages of spinal anesthesia formulations differ depending on multiple variables, such as depth of anesthesia, level of analgesia, and desired duration of effects. Furthermore, length of stay in the hospital is also a crucial variable to take into account when using spinal anesthesia due to its implications for patient comfort, quality of care, and return to daily life. Hyperbaric bupivacaine is a mainstay agent in regard to cesarean section anesthesia, with the most commonly used dosages being 1.8 mL and 2.0 mL. This study aims to assess the difference in duration of stay in the post-anesthesia care unit between patients receiving 1.8 mL and 2.0 mL of 0.5% hyperbaric bupivacaine. Of the 306 patients who underwent elective cesarean sections, 63 patients received 2.0 mL of 0.5% hyperbaric bupivacaine and 243 patients received 1.8 mL of 0.5% hyperbaric bupivacaine.